Please assess the completion status of the following clinical trial:

Trial Title: Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* candidates to Lung resection surgery at Hospital General Universitario Gregorio Marañón (males and females)~* willing to participate and sign informed consent~* age \> 18 años and legal capable~* no urgent surgery.~* FEV1 \>50% or CVF \> 50%~* no previous steroids or immunosuppressors chronic treatment (three months before the surgery)~Exclusion Criteria:~* pregnancy and breast feeding~* propofol or sevoflurane hypersensibility.~* have received blood derivate product within 10 days before surgery.~* when protective pulmonary ventilation is not possible during one Lung ventilation.~* Heart failure \> II NYHA within one week before surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- propofol (Type: ACTIVE_COMPARATOR): propofol doses to maintain hypnoses between 40-60 bis(Bispectral Index Scale)during the lung resection surgery
- sevoflurane (Type: EXPERIMENTAL): Sevoflurane doses to maintain hypnoses between 40-60 bis(Bispectral Index Scale)during the lung resection surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).